Literature DB >> 9535550

Regulation of podocyte structure during the development of nephrotic syndrome.

W E Smoyer1, P Mundel.   

Abstract

Nephrotic syndrome is a common kidney disease seen in both children and adults. The clinical syndrome includes massive proteinuria, hypoalbuminemia, edema, and usually hypercholesterolemia. Development of these clinical changes is closely correlated with profound structural changes in glomerular epithelial cells, or podocytes, which together with the glomerular basement membrane and endothelium comprise the kidney's blood filtration barrier. Although relatively little is known about the cellular or molecular changes which occur within podocytes during the development of nephrotic syndrome, cytoskeletal proteins very likely play a central role in these changes since they are primarily responsible for the maintenance of cell structure in almost all cells. This review focuses on: (a) the structure and function of podocytes in both the normal state and during nephrotic syndrome and (b) the potential roles of several cytoskeleton-associated proteins identified in podocytes in the development of and/or recovery from the pathophysiological cytoskeletal changes which occur in podocytes during nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535550     DOI: 10.1007/s001090050206

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  47 in total

1.  Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.

Authors:  Shipra Agrawal; Adam J Guess; Rainer Benndorf; William E Smoyer
Journal:  Mol Pharmacol       Date:  2011-06-02       Impact factor: 4.436

Review 2.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

3.  Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation.

Authors:  Moin A Saleem; Lan Ni; Ian Witherden; Karl Tryggvason; Vesa Ruotsalainen; Peter Mundel; Peter W Mathieson
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

4.  Activation of adenosine 2A receptors preserves structure and function of podocytes.

Authors:  Alaa S Awad; Michael Rouse; Lixia Liu; Amy L Vergis; Diane L Rosin; Joel Linden; John R Sedor; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

Review 5.  Roles of adaptor proteins in podocyte biology.

Authors:  Tae-Sun Ha
Journal:  World J Nephrol       Date:  2013-02-06

Review 6.  Podocytes from the diagnostic and therapeutic point of view.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pflugers Arch       Date:  2017-05-16       Impact factor: 3.657

7.  Deficiency of the tensin2 gene in the ICGN mouse: an animal model for congenital nephrotic syndrome.

Authors:  A-Ri Cho; Kozue Uchio-Yamada; Takeshi Torigai; Tomomi Miyamoto; Ichiro Miyoshi; Junichiro Matsuda; Tsutomu Kurosawa; Yasuhiro Kon; Atsushi Asano; Nobuya Sasaki; Takashi Agui
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957

8.  Immunohistochemical and electronmicroscopic features of mesenchymal-to-epithelial transition in human developing, postnatal and nephrotic podocytes.

Authors:  Natalija Filipovic; Katarina Vukojevic; Ivana Bocina; Marijan Saraga; Merica Glavina Durdov; Boris Kablar; Mirna Saraga-Babic
Journal:  Histochem Cell Biol       Date:  2016-10-01       Impact factor: 4.304

9.  Podocyte injury induces nuclear translocation of WTIP via microtubule-dependent transport.

Authors:  Jane H Kim; Martha Konieczkowski; Amitava Mukherjee; Sam Schechtman; Shenaz Khan; Jeffrey R Schelling; Michael D Ross; Leslie A Bruggeman; John R Sedor
Journal:  J Biol Chem       Date:  2010-01-10       Impact factor: 5.157

10.  High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling.

Authors:  Tae-Sun Ha
Journal:  J Mol Med (Berl)       Date:  2010-01-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.